Chargement en cours...
Pharmacodynamic Biomarkers for Emerging LRRK2 Therapeutics
Genetic studies have identified variants in the LRRK2 gene as important components of Parkinson’s disease (PD) pathobiology. Biochemical and emergent biomarker studies have coalesced around LRRK2 hyperactivation in disease. Therapeutics that diminish LRRK2 activity, either with small molecule kinase...
Enregistré dans:
| Publié dans: | Front Neurosci |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2020
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7438883/ https://ncbi.nlm.nih.gov/pubmed/32903744 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnins.2020.00807 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|